510(k) K771139

CRP-WELLCOTEST by Burroughs Wellcome Co. — Product Code DCN

K771139 is an FDA 510(k) premarket notification submitted by Burroughs Wellcome Co. for the device "CRP-WELLCOTEST". The FDA issued a decision of Substantially Equivalent on July 14, 1977. The device falls under product code DCN (System, Test, C-Reactive Protein), a Class II device regulated under 21 CFR 866.5270. Burroughs Wellcome Co. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
July 14, 1977
Date Received
June 27, 1977
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Test, C-Reactive Protein
Device Class
Class II
Regulation Number
866.5270
Review Panel
IM
Submission Type